Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Bone Neoplasms × 90 days × Clear all

Phase

Phase NA 10 Phase 2 4 Phase 1 3 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 114 Neoplasms 69 Breast Neoplasms 69 Colorectal Neoplasms 61 Prostatic Neoplasms 51 Ovarian Neoplasms 50 Melanoma 46 Neoplasm Metastasis 45 Pancreatic Neoplasms 42 Lung Neoplasms 42 Recurrence 39 Multiple Myeloma 39 Leukemia, Myeloid, Acute 37 Stomach Neoplasms 35 Lymphoma 31 Triple Negative Breast Neoplasms 30 Glioblastoma 30 Squamous Cell Carcinoma of Head and Neck 29 Lymphoma, Non-Hodgkin 27 Carcinoma, Renal Cell 27 Lymphoma, Large B-Cell, Diffuse 26 Endometrial Neoplasms 26 Precursor Cell Lymphoblastic Leukemia-Lymphoma 25 Leukemia, Lymphocytic, Chronic, B-Cell 25 Small Cell Lung Carcinoma 24 Sarcoma 24 Myelodysplastic Syndromes 23 Uterine Cervical Neoplasms 21 Lymphoma, Follicular 21 Advanced Solid Tumors 21

Interventions

endostar protein 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06562673 2025-12-29

IACE-OS

Shanghai 6th People's Hospital

Phase 1/2 Completed

Bone Neoplasms, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡